ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

ClinicalTrials.gov ID: NCT04497844

Public ClinicalTrials.gov record NCT04497844. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Study identification

NCT ID
NCT04497844
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
696 participants

Conditions and interventions

Interventions

  • Abiraterone acetate (AA) Drug
  • Niraparib Drug
  • Placebo for Niraparib Drug
  • Prednisone Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2020
Primary completion
Jan 6, 2025
Completion
Oct 31, 2027
Last update posted
Apr 12, 2026

2020 – 2027

United States locations

U.S. sites
53
U.S. states
23
U.S. cities
48
Facility City State ZIP Site status
Urology Centers Of Alabama Homewood Alabama 35209
Mayo Clinic Arizona Phoenix Arizona 85054
Urological Associates of Southern Arizona, P.C. Tucson Arizona 85741
Greater Los Angeles VA Healthcare System Los Angeles California 90073
University of California Irvine Medical Center Chao Family Comprehensive Cancer Center Orange California 92868
San Bernardino Urological Associates San Bernardino California 92404
University of San Francisco California San Francisco California 94158
Rocky Mountain Cancer Centers Colorado Springs Colorado 80907
AdventHealth Medical Group Urology of Denver Denver Colorado 80210
Colorado Clinical Research Lakewood Colorado 80228
Eastern Connecticut Hematology & Oncology Assoc. Norwich Connecticut 06360
Advanced Urology Institute Daytona Beach Florida 32114
Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center Fort Lauderdale Florida 33308
University of Florida Health Jacksonville Jacksonville Florida 32209
Cancer Specialists of North Florida Jacksonville Florida 32256
Urology of Indiana Greenwood Indiana 46143
First Urology Jeffersonville Indiana 47130
Ochsner Clinic Foundation New Orleans Louisiana 70121
Baltimore VA Medical Center Baltimore Maryland 21201
Maryland Oncology Hematology, PA Columbia Maryland 21044
Chesapeake Urology Associates Towson Maryland 21204
Michigan Institute of Urology Troy Michigan 48084
Mosaic Life Care Saint Joseph Missouri 64507
St. Louis VA Medical Center St Louis Missouri 63109
GU Research Network Omaha Nebraska 68130
New York Oncology Hematology Albany New York 12206
Manhattan VAMC New York New York 10010
Mount Sinai New York New York 10029
Memorial Sloan Kettering Cancer Center New York New York 10065
Associated Medical Professionals Syracuse New York 13210
Montefiore Medical Center The Bronx New York 10461
Durham VAMC Durham North Carolina 27705
Stephenson Cancer Center Oklahoma City Oklahoma 73104
VA Portland Health Care System Portland Oregon 97239
Oregon Oncology Specialists Salem Oregon 97301
Keystone Urology Specialists Lancaster Pennsylvania 17604
Philadelphia VA Medical Center Philadelphia Pennsylvania 19104
University of Pennsylvania Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center (UPMC) Pittsburgh Pennsylvania 15232
Ralph H. Johnson Veterans Affairs Medical Center Charleston South Carolina 29401
Prisma Health Seneca South Carolina 29672
Urology Associates Nashville Tennessee 37209
Texas Oncology-Austin Austin Texas 78731
Texas Oncology - Northeast Denton Texas 76201
Houston Metro Urology Houston Texas 77027
Texas Oncology P A New Braunfels Texas 78130
Texas Oncology - Northeast 1 Tyler Texas 75702
University of Utah Huntsman Cancer Institute Salt Lake City Utah 84112
Virginia Oncology Associates Norfolk Virginia 23502
Virginia Commonwealth University - Massey Cancer Center Richmond Virginia 23298
VA Puget Sound Healthcare System Seattle Washington 98108
Fred Hutchinson Cancer Research Center Seattle Washington 98109
MultiCare Health System Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 334 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04497844, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04497844 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →